arrow
I

Irma Convertino

pharmacology and pharmacovigilance
H指数:13
被引数:669

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

SodiuM glucose cotrANsporter-2 (SGLT-2) inhibitors in the treatment of type II DiAbetes in Tuscany: utiLizatiOn patteRns; and relatEd clinical use evaluation; the MANDALORE study protocol

钠葡萄糖协同转运蛋白-2 (SGLT-2) 抑制剂在托斯卡纳地区治疗II型糖尿病中的应用模式及相关临床使用评估;MANDALORE研究方案

2026-04-030
OAAI
Biosimilars approvals by thirteen regulatory authorities: A cross-national comparison

13个监管机构批准的生物仿制药: 跨国比较

2023-10-012
OAAI
Trajectories of Adherence to Biologic Disease-Modifying Anti-Rheumatic Drugs in Tuscan Administrative Databases: The Pathfinder Study
2021-12-083
OAAI
Validation of algorithms for selecting rheumatoid arthritis patients in the Tuscan healthcare administrative databases
2021-10-135
OAAI